TenderlineUK
Procurement Intelligence
Official OCDS
Find a Tender
complete
Official procurement procedure

Requirement For Producer Cell Line For GMP Viral Vector Packaging

Disposable non-chemical medical consumables and haematological consumables
UK
Published value
Not published
Submission deadline Not published
Lots published1
Procurement Executive Summary
AI & Search Synopsis
Generated from official OCDS record
Tenderline Synopsis: NHS Blood and Transplant: "Requirement For Producer Cell Line For GMP Viral Vector Packaging". Published status: complete. Published value: Value not published. 1 published lot. Submission deadline not published. See the official notice for participation instructions.
Contracting AuthorityNHS Blood and TransplantScope & CategoriesNot publishedSubmission Window
complete
No deadline published
Submission GatewayDirect notice routeLegal Basis & RegimeStandard procurementEstimated Value (exc. VAT)Not published
Bidder Intelligence · Authority Profile: NHS Blood and Transplant
Market Analytics
View Authority Profile →
Derived from OCDS awards & bid statistics
Published history for NHS Blood and Transplant. These figures describe retained records, not a forecast of bids or a measure of buyer bias.
Published-to-award variance
Not availableInsufficient comparable data
Requires at least 5 comparable procedures
Competition Density
1.7Bids / Report
56.5% of reports have one bid
Supplier ConcentrationNo estimate
Insufficient attributable awardsNo concentration estimate available
Payment Terms
Check noticePublished terms
Payment obligations depend on the applicable regime and contract. Consult the official documents.
Coverage: 27 active published awards; 23 bid reports (which may be per lot). Supplier values exclude multi-supplier awards, frameworks and DPS, and use GBP only. They are published award values, not payments. Published-to-award variance compares single-lot, single-award, single-supplier GBP procedures with explicitly non-framework/non-DPS status; increases remain in the average. Unpublished data stays unknown. Awarded suppliers are winners, not all bidders.
Procedure terms
Contracting AuthorityNHS Blood and Transplant
Procedure methodNot published
Procurement categoryNot published
Statuscomplete
Framework / DPSFramework
CompetitionNot published
Above thresholdNot published
Legal basisNot published
Tender period startsNot published
Clarification deadlineNot published
Electronic submissionNot published
Submission languagesNot published
Published14 Apr 2022, 15:34 BST
Last source update14 Apr 2022, 15:34 BST
Recurring procurementNot published
ClassificationDisposable non-chemical medical consumables and haematological consumables
Delivery area
UK
OCIDocds-h6vhtk-032e03
What is being bought
NHSBT’s Clinical Biotechnology Centre for the purpose of specifying the user requirement for HEK293-derived production cell line for the GMP-production of viral vectors and other recombinant proteins. The CBC has an MHRA licence for the manufacture of investigational medicinal gene therapy and recombinant protein products for use in clinical trials. In order to manufacture GMP-grade viral vectors and recombinant proteins for clinical trials, a GMP-qualified producer cell line is required.
What changed
From the official release history
  1. Status changed to complete
    14 Apr 2022, 15:34 BST
  2. Official notice release published
    14 Apr 2022, 15:34 BST
  3. Buyer information updated
    14 Apr 2022, 15:34 BST
Lots and requirements (1)
Published by the contracting authority
  • Lot 1 · #1
    Individual lot title not published
    cancelled
    Published valueNot published
    NHSBT’s Clinical Biotechnology Centre for the purpose of specifying the user requirement for HEK293-derived production cell line for the GMP-production of viral vectors and other recombinant proteins. The CBC has an MHRA licence for the manufacture of investigational medicinal gene therapy and recombinant protein products for use in clinical trials. In order to manufacture GMP-grade viral vectors and recombinant proteins for clinical trials, a GMP-qualified producer cell line is required.
    Contract periodNot published
    EligibilityNot published
    Options / renewalNot published
Timeline
  1. Procedure published
    14 Apr 2022, 15:34 BST
  2. Award active
    Not published · Not published
  3. Contract active
    Signed 7 Apr 2022, 00:00 BST · Not published
Commercial outcome and competition
Awards
LIFE TECHNOLOGIES LIMITED
Not published · Not published · active
Contracts
Contract
Not published · signed 7 Apr 2022, 00:00 BST · active
Bid statistics
bids: 1 (lot 1)
electronicBids: 1 (lot 1)
foreignBidsFromEU: 0 (lot 1)
foreignBidsFromNonEU: 0 (lot 1)
highestValidBidValue: 111000 (lot 1)
lowestValidBidValue: 111000 (lot 1)
smeBids: 0 (lot 1)
Buyer and organisations in this procedure

NHS Blood and Transplant

Contracting authority GB-FTS-17015
View buyer profile

  • NHS Blood and Transplant
    buyer

    NHS Blood and Transplant
    500 North Bristol Park, Bristol, UKK11, BS34 7QH
    marnie.watkins@nhsbt.nhs.uk
    +44 1179217241

  • LIFE TECHNOLOGIES LIMITED
    supplier

    SC083107
    3 Fountain Drive, Inchinnan Business Park,, Paisley, UK, PA4 9RF

  • NHS Blood and Transplant
    reviewBody

    500 North Bristol Park, Bristol, BS34 7QH
Documents (0)
Official links; attachments are not copied
No data
No linked documents are published
Related procedures (0)
No data
No related procedures published